Bordetella Pertussis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bordetella Pertussis Tests Market Report Overview
The Bordetella Pertussis Tests market size was valued at $33.8 million in 2023. The market is expected to register a negative CAGR of less than 1% during 2023-2033. Bordetella pertussis is also called whooping cough. It is an upper respiratory infectious disease caused by the gram-negative bacterium Bordetella pertussis. Bordetella pertussis is highly contagious and can affect people of any age, but is particularly serious in babies under six months of age.
Bordetella Pertussis Tests Market Outlook 2023-2023 ($ Million)
Buy The Full Report for More Insights on The Bordetella Pertussis Tests Market Forecast
The Bordetella Pertussis Tests market research report explains the market behavior, which will help identify quantitative market trends within the In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the Bordetella Pertussis Tests market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2023) | $33.8 Million |
CAGR (2023-2033) | >(1)% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments | · Bordetella pertussis Nucleic Acid Amplification Tests (NAATs)
· Bordetella pertussis Other Tests · Bordetella pertussis Tests Enzyme Immunoassay (EIA) Tests |
Key Regions |
|
Key Companies | · DiaSorin SpA
· Meridian Bioscience Inc · Quidelortho Corp · Tecan Group Ltd · Revvity Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Bordetella Pertussis Tests Market Dynamics
The Bordetella Pertussis Tests market is expected to increase during the forecast period primarily due to sales rise in the US, Germany, Russia, Australia, China, New Zealand, Brazil, and Saudi Arabia. In addition, fewer vaccinations during the COVID-19 pandemic will lead to infants and children being more exposed to Pertussis cases, which will further boost the demand for Bordetella Pertussis Tests. However, factors such as decreasing population, disease awareness, and switch in device usage to respiratory panels in developed countries are expected to negatively impact the market in the coming years.
Bordetella Pertussis Tests Market Segments
The key segments in the Bordetella Pertussis Tests market are Bordetella pertussis Nucleic Acid Amplification Tests (NAATs), Bordetella pertussis Other Tests, and Bordetella pertussis Tests Enzyme Immunoassay (EIA) Tests. In 2023, the Bordetella pertussis Nucleic Acid Amplification Tests (NAATs) segment dominated the market. NAAT involves the amplification of specific nucleic acid sequences of the B. pertussis bacterium by targeting specific nucleic acid sequences. This test exhibits better sensitivity in comparison to culture or antigen identification methods.
Bordetella Pertussis Tests Market Analysis by Segments, 2023 (%)
Buy The Full Report to Know More About the Bordetella Pertussis Tests Market Segments
Bordetella Pertussis Tests Market Analysis by Segments, 2023 (%)
The key regions in the Bordetella Pertussis Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America dominated the Bordetella Pertussis Tests market, and it is expected to grow in Canada and Mexico during the forecast period. The growth of the Canadian B. Pertussis Tests market is attributed to an increase in the number of incident cases and suspected and confirmatory cases opting for B. pertussis tests.
Bordetella Pertussis Tests Market Analysis by Regions, 2023 (%)
Buy The Full Report for More Regional Insights into The Bordetella Pertussis Tests Market
Bordetella Pertussis Tests Market – Competitive Landscape
The key companies in the Bordetella Pertussis Tests market are:
- DiaSorin SpA
- Meridian Bioscience Inc
- Quidelortho Corp
- Tecan Group Ltd
- Revvity Inc
In 2023, DiaSorin SpA accounted for the highest Bordetella Pertussis Tests market share, followed by Meridian Bioscience Inc.
Bordetella Pertussis Tests Market Analysis by Companies, 2023 (%)
Buy The Full Report for More Company Insights into The Bordetella Pertussis Tests Market
Segments Covered in this Report
Bordetella Pertussis Tests Segment Outlook ($ Million, 2015-2033)
- Bordetella pertussis Nucleic Acid Amplification Tests (NAATs)
- Bordetella pertussis Other Tests
- Bordetella pertussis Tests Enzyme Immunoassay (EIA) Tests
Bordetella Pertussis Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
Currently marketed Bordetella Pertussis Tests market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Bordetella Pertussis Tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Bordetella Pertussis Tests market.
- Competitive dynamics insights and trends provided for the Bordetella Pertussis Tests market.
Thoroughly understand the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Meridian Biosciences Inc, Hologic Inc, bioMerieux SA, DiaSorin SpA, Quidelortho Corp, Tecan Group Ltd, c, Qiagen NV, Revvity Inc, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Bordetella Pertussis Tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Bordetella Pertussis Tests market.
- Competitive dynamics insights and trends provided for the Bordetella Pertussis Tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
This report provides:
- Insightful review of the key industry trends.
- Annualized total Bordetella Pertussis Tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Bordetella Pertussis Tests market.
- Competitive dynamics insights and trends provided for the Bordetella Pertussis Tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Hologic Inc
bioMerieux SA
DiaSorin SpA
Quidelortho Corp
Tecan Group Ltd
Revvity Inc
Qiagen NV
Others
Frequently asked questions
-
What was the Bordetella Pertussis Tests market size in 2023?
The Bordetella Pertussis Tests market size was $33.8 million in 2023.
-
What will be the growth rate of the Bordetella Pertussis Tests market during the forecast period?
The Bordetella Pertussis Tests market is expected to register a negative CAGR of less than 1% during 2023-2033.
-
Which was the leading segment in the Bordetella Pertussis Tests market in 2023?
In 2023, the Bordetella pertussis Nucleic Acid Amplification Tests (NAATs) segment dominated the market.
-
Which region dominated the Bordetella Pertussis Tests market in 2023?
North America was the largest region in the Bordetella Pertussis Tests market in 2023.
-
Which are the key companies operating in the Bordetella Pertussis Tests market?
The key companies in the Bordetella Pertussis Tests market are DiaSorin SpA, Meridian Bioscience Inc., Quidelortho Corp, Tecan Group Ltd, and Revvity Inc. among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.